Concepedia
7
Publications
232
Citations
H-Index
2013
Active since
Affiliations
Takeda (Japan)(Current)
Takeda (United States)
University of Chicago
Jennifer Matuszkiewicz is an author at Takeda (Japan) specializing in drug discovery, cell signaling, and immunology.
Top concepts
MedicineImmunologyBiochemistryPharmacologyCell SignalingDrug Discovery
Publications per year
2013–2019
Design of KDM4 Inhibitors with Antiproliferative Effects in Cancer Models
Young K. Chen, Tiziana Bonaldi, Alessandro Cuomo et al. · ACS Medicinal Chemistry Letters · 2017 · 83 citations · Full text
Discovery of TAK-659 an orally available investigational inhibitor of Spleen Tyrosine Kinase (SYK)
Betty Lam, Yasuyoshi Arikawa, Joshua Cramlett et al. · Bioorganic & Medicinal Chemistry Letters · 2016 · 60 citations · Full text
Biochemistry, Available Investigational Inhibitor, Medicine +7
Biological Characterization of TAK-901, an Investigational, Novel, Multitargeted Aurora B Kinase Inhibitor
Pamela Farrell, Lihong Shi, Jennifer Matuszkiewicz et al. · Molecular Cancer Therapeutics · 2013 · 44 citations · Full text
Aurora B Inhibitor TAK-901 Synergizes with BCL-xL Inhibition by Inducing Active BAX in Cancer Cells
Saomi Murai, Jennifer Matuszkiewicz, Yuumi Okuzono et al. · Anticancer Research · 2017 · 13 citations · Full text
MET Tyrosine Kinase Inhibition Enhances the Antitumor Efficacy of an HGF Antibody
Pamela Farrell, Jennifer Matuszkiewicz, Deepika Balakrishna et al. · Molecular Cancer Therapeutics · 2017 · 12 citations
Rows per page
1–5 of 7